Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Sell
120,444
-48,082
-29% -$13.3M 0.2% 98
2025
Q4
$46.4M Buy
168,526
+45,159
+37% +$12.7M 0.29% 84
2025
Q3
$35.6M Buy
123,367
+33,171
+37% +$9.81M 0.25% 80
2025
Q2
$29.8M Buy
+90,196
New +$29.1M 0.26% 81
2024
Q4
Sell
-100,192
Closed -$34.7M 703
2024
Q3
$34.7M Buy
100,192
+99,433
+13,101% +$34.2M 0.79% 34
2024
Q2
$251K Sell
759
-72,094
-99% -$24.9M 0.01% 457
2024
Q1
$26.5M Buy
72,853
+387
+0.5% +$127K 0.86% 28
2023
Q4
$21.7M Buy
+72,466
New +$21.2M 0.85% 29
2023
Q3
Sell
-260,000
Closed -$73M 226
2023
Q2
$73M Buy
260,000
+150,000
+136% +$39.1M 13.16% 1
2023
Q1
$28.1M Buy
110,000
+55,000
+100% +$16M 3.72% 8
2022
Q4
$18.2M Buy
+55,000
New +$17.4M 2.58% 10

Other funds holding CI

Marex Group's CI Position: Q1 2026 in Review

Marex Group reduced its Cigna (CI) stake by 29% in Q1 2026, selling an estimated $13.3M and leaving 120,444 shares worth $32.1M. The position accounts for 0.2% of the portfolio, ranked #98.

Marex Group first reported a position in CI in Q4 2022 and has held it in 11 quarters since. The position peaked at $73M in Q2 2023. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Marex Group held 120,444 shares of Cigna worth $32.1M as of Q1 2026.
  • Marex Group sold 48,082 Cigna shares in Q1 2026, an estimated $13.3M.
  • Cigna made up 0.2% of Marex Group's portfolio in Q1 2026, its #98 holding.
  • Marex Group first reported a position in Cigna in Q4 2022 and has held it in 11 quarters since.
  • Marex Group's Cigna position peaked at $73M in Q2 2023.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.